Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Macrophage markers WP4146,0.001896232447153293,44.11538461538461,276.5102141421409,"['CD163', 'CD83']",0.11673981194954333,0,0,2
2,Pyrimidine metabolism and related diseases WP4225,0.001896232447153293,44.11538461538461,276.5102141421409,"['DPYD', 'TYMP']",0.11673981194954333,0,0,2
3,Biomarkers for pyrimidine metabolism disorders WP4584,0.0026349737728098457,35.287179487179486,209.5663968667541,"['DPYD', 'TYMP']",0.11673981194954333,0,0,2
4,Fluoropyrimidine Activity WP1601,0.003487179579783917,29.4017094017094,166.37433610342708,"['DPYD', 'TYMP']",0.11673981194954333,0,0,2
5,Toll-like Receptor Signaling Pathway WP75,0.004016353402460957,6.785501489572989,37.43819632800134,"['SPP1', 'LY96', 'MAP3K8', 'IKBKE']",0.11673981194954333,0,0,4
6,Complement system WP2806,0.004736830324203359,9.897546897546897,52.97550208798342,"['CD93', 'SPP1', 'F13A1']",0.11673981194954333,0,0,3
7,Iron metabolism in placenta WP2007,0.005521477592208131,22.044871794871796,114.61370843216174,"['TFRC', 'HAMP']",0.11673981194954333,0,0,2
8,Gastric Cancer Network 2 WP2363,0.006698426369039544,19.59259259259259,98.07821933687204,"['PLAC8', 'RNF144B']",0.11808256205025243,0,0,2
9,Statin inhibition of cholesterol production WP430,0.00797855148988192,17.630769230769232,85.17421797203797,"['APOC1', 'PLTP']",0.11808256205025243,0,0,2
10,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.00797855148988192,17.630769230769232,85.17421797203797,"['SPP1', 'IGF1']",0.11808256205025243,0,0,2
11,3q29 copy number variation syndrome WP4906,0.009903263705390958,7.413419913419913,34.2121241627348,"['TFRC', 'HIF1A', 'HAMP']",0.13324391167253288,0,0,3
12,"COVID-19, thrombosis and anticoagulation WP4927",0.01148424330911571,inf,inf,['F13A1'],0.13778286864819314,0,0,1
13,Regulation of toll-like receptor signaling pathway WP1449,0.012102549273152099,4.844950213371266,21.38725347857774,"['SPP1', 'LY96', 'MAP3K8', 'IKBKE']",0.13778286864819314,0,0,4
14,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.01645885627641623,6.058441558441558,24.881362570830873,"['HSPA5', 'HSPA1B', 'HSPA1A']",0.16364067143114408,0,0,3
15,Vitamin D Receptor Pathway WP2877,0.01741353211086634,5.922943722943723,23.99092896394502,"['BCL6', 'SPP1', 'HIF1A']",0.16364067143114408,0,0,3
16,Lung fibrosis WP3624,0.017690883397961522,11.009615384615385,44.420559426307264,"['SPP1', 'IGF1']",0.16364067143114408,0,0,2
17,"GPCRs, Class A Rhodopsin-like WP455",0.021646779624626574,9.783475783475783,37.49907046463806,"['CX3CR1', 'GPR65']",0.1877814512800202,0,0,2
18,Hfe effect on hepcidin production WP3924,0.022838284615137594,87.15189873417721,329.3746525930555,['HAMP'],0.1877814512800202,0,0,1
19,PPAR signaling pathway WP3942,0.03053133480819293,8.0,27.91201401594004,"['ACSL1', 'PLTP']",0.21919147004857792,0,0,2
20,Endochondral Ossification with Skeletal Dysplasias WP4808,0.03294308760583463,7.651059085841695,26.112864388811154,"['SPP1', 'IGF1']",0.21919147004857792,0,0,2
21,Endochondral Ossification WP474,0.03294308760583463,7.651059085841695,26.112864388811154,"['SPP1', 'IGF1']",0.21919147004857792,0,0,2
22,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.034063539264306025,43.56962025316456,147.2447383720961,['HIF1A'],0.21919147004857792,0,0,1
23,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.034063539264306025,43.56962025316456,147.2447383720961,['HIF1A'],0.21919147004857792,0,0,1
24,Ferroptosis WP4313,0.04060420027607933,6.765285996055227,21.675189952442825,"['TFRC', 'ACSL1']",0.24755161337822612,0,0,2
25,Thiamine metabolic pathways WP4297,0.04516144298116287,29.042194092827003,89.95853273106034,['SLC25A19'],0.24755161337822612,0,0,1
26,Caloric restriction and aging WP4191,0.04516144298116287,29.042194092827003,89.95853273106034,['IGF1'],0.24755161337822612,0,0,1
27,"GPCRs, Class B Secretin-like WP334",0.04516144298116287,29.042194092827003,89.95853273106034,['ADGRE2'],0.24755161337822612,0,0,1
28,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.054680272212612124,5.669975186104218,16.478378362360733,"['HSPA5', 'YBX3']",0.26483073836559295,0,0,2
29,Pyrimidine metabolism WP4022,0.054680272212612124,5.669975186104218,16.478378362360733,"['DPYD', 'TYMP']",0.26483073836559295,0,0,2
30,HIF1A and PPARG regulation of glycolysis WP2456,0.05613341980128372,21.77848101265823,62.72254637620278,['HIF1A'],0.26483073836559295,0,0,1
31,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.06050719949818591,2.8467368421052632,7.9850766902124715,"['SPP1', 'IGF1', 'JAK3', 'HIF1A']",0.26483073836559295,0,0,4
32,Cytokines and Inflammatory Response WP530,0.06698087932138638,17.42025316455696,47.09300800794644,['IL15'],0.26483073836559295,0,0,1
33,Osteoclast Signaling WP12,0.06698087932138638,17.42025316455696,47.09300800794644,['SPP1'],0.26483073836559295,0,0,1
34,Fatty acid transporters WP5061,0.06698087932138638,17.42025316455696,47.09300800794644,['ACSL1'],0.26483073836559295,0,0,1
35,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.06698087932138638,17.42025316455696,47.09300800794644,['SPP1'],0.26483073836559295,0,0,1
36,Genes targeted by miRNAs in adipocytes WP1992,0.06698087932138638,17.42025316455696,47.09300800794644,['IGF1'],0.26483073836559295,0,0,1
37,Development and heterogeneity of the ILC family WP3893,0.07770521614319473,14.514767932489452,37.08280653413141,['IL15'],0.26483073836559295,0,0,1
38,Differentiation of white and brown adipocyte WP2895,0.07770521614319473,14.514767932489452,37.08280653413141,['PLAC8'],0.26483073836559295,0,0,1
39,Apoptosis WP254,0.0801216025301995,4.50164365548981,11.363092881658284,"['CASP4', 'IGF1']",0.26483073836559295,0,0,2
40,Cardiac Hypertrophic Response WP2795,0.0801216025301995,4.50164365548981,11.363092881658284,"['IGF1', 'IKBKE']",0.26483073836559295,0,0,2
41,Oncostatin M Signaling Pathway WP2374,0.08352076935642307,4.388461538461539,10.895057674019615,"['JAK3', 'HIF1A']",0.26483073836559295,0,0,2
42,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.08830780973451031,12.439421338155515,30.18956414904858,['ACSL1'],0.26483073836559295,0,0,1
43,"NAD metabolism, sirtuins and aging WP3630",0.08830780973451031,12.439421338155515,30.18956414904858,['HIF1A'],0.26483073836559295,0,0,1
44,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.08830780973451031,12.439421338155515,30.18956414904858,['JAK3'],0.26483073836559295,0,0,1
45,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.08830780973451031,12.439421338155515,30.18956414904858,['LTC4S'],0.26483073836559295,0,0,1
46,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.08830780973451031,12.439421338155515,30.18956414904858,['IGF1'],0.26483073836559295,0,0,1
47,Omega-3/Omega-6 FA synthesis WP4723,0.08830780973451031,12.439421338155515,30.18956414904858,['ACSL1'],0.26483073836559295,0,0,1
48,RalA downstream regulated genes WP2290,0.08830780973451031,12.439421338155515,30.18956414904858,['YBX3'],0.26483073836559295,0,0,1
49,Apoptosis Modulation and Signaling WP1772,0.0904487234820749,4.1782661782661785,10.04025738787798,"['CASP4', 'HSPA1A']",0.26483073836559295,0,0,2
50,MECP2 and Associated Rett Syndrome WP3584,0.0904487234820749,4.1782661782661785,10.04025738787798,"['BCL6', 'IGF1']",0.26483073836559295,0,0,2
51,Omega-9 FA synthesis WP4724,0.09879002446927783,10.882911392405063,25.191313241789448,['ACSL1'],0.26483073836559295,0,0,1
52,Osteopontin Signaling WP1434,0.09879002446927783,10.882911392405063,25.191313241789448,['SPP1'],0.26483073836559295,0,0,1
53,Peptide GPCRs WP24,0.09879002446927783,10.882911392405063,25.191313241789448,['CX3CR1'],0.26483073836559295,0,0,1
54,PPAR-alpha pathway WP2878,0.09879002446927783,10.882911392405063,25.191313241789448,['PLTP'],0.26483073836559295,0,0,1
55,TYROBP causal network in microglia WP3945,0.10846021141635197,3.731042007637752,8.288031829887728,"['DPYD', 'SPP1']",0.26483073836559295,0,0,2
56,Sleep regulation WP3591,0.10915320973176466,9.672292545710267,21.424154972567592,['PER3'],0.26483073836559295,0,0,1
57,Apoptosis Modulation by HSP70 WP384,0.10915320973176466,9.672292545710267,21.424154972567592,['HSPA1A'],0.26483073836559295,0,0,1
58,Cardiac Progenitor Differentiation WP2406,0.10915320973176466,9.672292545710267,21.424154972567592,['IGF1'],0.26483073836559295,0,0,1
59,Differentiation Pathway WP2848,0.10915320973176466,9.672292545710267,21.424154972567592,['IGF1'],0.26483073836559295,0,0,1
60,Eicosanoid Synthesis WP167,0.10915320973176466,9.672292545710267,21.424154972567592,['LTC4S'],0.26483073836559295,0,0,1
61,"GPCRs, Other WP117",0.10915320973176466,9.672292545710267,21.424154972567592,['ADGRE2'],0.26483073836559295,0,0,1
62,Imatinib and Chronic Myeloid Leukemia WP3640,0.11939870004675697,8.70379746835443,18.498067309527865,['PIM1'],0.2761094938581255,0,0,1
63,Angiogenesis WP1539,0.11939870004675697,8.70379746835443,18.498067309527865,['HIF1A'],0.2761094938581255,0,0,1
64,Pre-implantation embryo WP3527,0.11939870004675697,8.70379746835443,18.498067309527865,['ZFP36'],0.2761094938581255,0,0,1
65,Adipogenesis WP236,0.12349447841124482,3.4364002011060832,7.187433194807851,"['IGF1', 'HIF1A']",0.2769270121949126,0,0,2
66,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.12349447841124482,3.4364002011060832,7.187433194807851,"['IGF1', 'IKBKE']",0.2769270121949126,0,0,2
67,Fatty Acid Biosynthesis WP357,0.1295278151898216,7.9113924050632916,16.169775568004997,['ACSL1'],0.28191348011902345,0,0,1
68,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.1295278151898216,7.9113924050632916,16.169775568004997,['HIF1A'],0.28191348011902345,0,0,1
69,T-cell receptor (TCR) signaling pathway WP69,0.13899992259974492,3.1846153846153844,6.28414390548322,"['CD83', 'MAP3K8']",0.2868360463429895,0,0,2
70,IL-9 signaling pathway WP22,0.13954186038307598,7.251054852320675,14.28015961649527,['JAK3'],0.2868360463429895,0,0,1
71,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13954186038307598,7.251054852320675,14.28015961649527,['BCL6'],0.2868360463429895,0,0,1
72,SARS coronavirus and innate immunity WP4912,0.13954186038307598,7.251054852320675,14.28015961649527,['IKBKE'],0.2868360463429895,0,0,1
73,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.1494421264145521,6.6923076923076925,12.721046812181255,['IKBKE'],0.30297855766237963,0,0,1
74,Immune response to tuberculosis WP4197,0.1592298897871443,6.213381555153707,11.416506247693185,['PTPN2'],0.31421364917996475,0,0,1
75,SARS-CoV-2 mitochondrial interactions WP5038,0.1592298897871443,6.213381555153707,11.416506247693185,['IKBKE'],0.31421364917996475,0,0,1
76,Bladder cancer WP2828,0.1689064128776412,5.79831223628692,10.311779290238556,['TYMP'],0.3204890911011653,0,0,1
77,Unfolded protein response WP4925,0.1689064128776412,5.79831223628692,10.311779290238556,['HSPA5'],0.3204890911011653,0,0,1
78,Photodynamic therapy-induced unfolded protein response WP3613,0.1689064128776412,5.79831223628692,10.311779290238556,['HSPA5'],0.3204890911011653,0,0,1
79,Neovascularisation processes WP4331,0.1784729440924883,5.435126582278481,9.366452900753186,['HIF1A'],0.33111602696479114,0,0,1
80,MAPK Signaling Pathway WP382,0.1874082345954013,2.0735249002965537,3.472046881142257,"['MAP3K8', 'HSPA1B', 'HSPA1A']",0.33111602696479114,0,0,3
81,PI3K-Akt signaling pathway WP4172,0.1874082345954013,2.0735249002965537,3.472046881142257,"['SPP1', 'IGF1', 'JAK3']",0.33111602696479114,0,0,3
82,IL-7 signaling pathway WP205,0.1879307180070436,5.114668652271035,8.550099037667783,['JAK3'],0.33111602696479114,0,0,1
83,TLR4 Signaling and Tolerance WP3851,0.1879307180070436,5.114668652271035,8.550099037667783,['IKBKE'],0.33111602696479114,0,0,1
84,Fatty acid beta-oxidation WP143,0.1879307180070436,5.114668652271035,8.550099037667783,['ACSL1'],0.33111602696479114,0,0,1
85,The influence of laminopathies on Wnt signaling WP4844,0.19728095551013644,4.829817158931083,7.839403719271221,['SPP1'],0.33950676064535107,0,0,1
86,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.19728095551013644,4.829817158931083,7.839403719271221,['HIF1A'],0.33950676064535107,0,0,1
87,Toll-like Receptor Signaling related to MyD88 WP3858,0.20652486398971595,4.574950033311126,7.216226372799638,['IKBKE'],0.3513296536836547,0,0,1
88,Melatonin metabolism and effects WP3298,0.21566363745761663,4.345569620253165,6.666257278813709,['PER3'],0.35504784047384974,0,0,1
89,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.21566363745761663,4.345569620253165,6.666257278813709,['IKBKE'],0.35504784047384974,0,0,1
90,Type 2 papillary renal cell carcinoma WP4241,0.22469845666263552,4.138034960819771,6.17806951297952,['HIF1A'],0.35504784047384974,0,0,1
91,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.22469845666263552,4.138034960819771,6.17806951297952,['LY96'],0.35504784047384974,0,0,1
92,Prion disease pathway WP3995,0.22469845666263552,4.138034960819771,6.17806951297952,['HSPA5'],0.35504784047384974,0,0,1
93,Hematopoietic Stem Cell Differentiation WP2849,0.22469845666263552,4.138034960819771,6.17806951297952,['PIM1'],0.35504784047384974,0,0,1
94,Ebola Virus Pathway on Host WP4217,0.22550335813879646,2.2975708502024292,3.4220484999733496,"['BST2', 'IKBKE']",0.35504784047384974,0,0,2
95,Hepatitis C and Hepatocellular Carcinoma WP3646,0.24246088998999527,3.7771051183269124,5.351836369951282,['HIF1A'],0.37772854440546627,0,0,1
96,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.251190800794001,3.619198312236287,5.000076161597849,['IGF1'],0.3872524845574183,0,0,1
97,Chemokine signaling pathway WP3929,0.25960877893883344,2.0763125763125765,2.8000725293903845,"['CX3CR1', 'JAK3']",0.3884197972591846,0,0,2
98,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.2598213508693194,3.4739240506329114,4.682019339125491,['ACSL1'],0.3884197972591846,0,0,1
99,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2598213508693194,3.4739240506329114,4.682019339125491,['BST2'],0.3884197972591846,0,0,1
100,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.26835365696580366,3.3398247322297956,4.393370950624418,['HSPA5'],0.39323110129642513,0,0,1
101,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.26835365696580366,3.3398247322297956,4.393370950624418,['IKBKE'],0.39323110129642513,0,0,1
102,Focal Adhesion WP306,0.280986489614495,1.958225295303947,2.4858665367648576,"['SPP1', 'IGF1']",0.40594633281097625,0,0,2
103,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.285127942351528,3.100361663652803,3.8903873864417946,['SPP1'],0.40594633281097625,0,0,1
104,Hepatitis B infection WP4666,0.28525958521852385,1.9361823361823363,2.4286613262696277,"['JAK3', 'IKBKE']",0.40594633281097625,0,0,2
105,TGF-beta Receptor Signaling WP560,0.2933720936412669,2.993016150152772,3.6703762049123134,['SPP1'],0.40961386659346694,0,0,1
106,Microglia Pathogen Phagocytosis Pathway WP3937,0.2933720936412669,2.993016150152772,3.6703762049123134,['FCER1G'],0.40961386659346694,0,0,1
107,IL-2 signaling pathway WP49,0.30152234530829386,2.8928270042194093,3.468242555497646,['JAK3'],0.4131972880150694,0,0,1
108,Cytosolic DNA-sensing pathway WP4655,0.30152234530829386,2.8928270042194093,3.468242555497646,['IKBKE'],0.4131972880150694,0,0,1
109,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.31754536241641085,2.7112341772151898,3.1101505255299986,['SPP1'],0.4311625104369615,0,0,1
110,Notch Signaling Pathway Netpath WP61,0.32542020506306935,2.628691983122363,2.951069492468955,['HIF1A'],0.4338936067507591,0,0,1
111,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.32542020506306935,2.628691983122363,2.951069492468955,['IKBKE'],0.4338936067507591,0,0,1
112,IL-4 signaling pathway WP395,0.3332053026464762,2.551005212211467,2.803545683659305,['JAK3'],0.4403070070685578,0,0,1
113,Modulators of TCR signaling and T cell activation WP5072,0.3409016651513667,2.477757685352622,2.6664667218283897,['MAP3K8'],0.4408506249510454,0,0,1
114,Regulatory circuits of the STAT3 signaling pathway WP4538,0.3409016651513667,2.477757685352622,2.6664667218283897,['JAK3'],0.4408506249510454,0,0,1
115,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.3485102913464345,2.4085794655414907,2.5388535526935234,['MAP3K8'],0.4408506249510454,0,0,1
116,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3485102913464345,2.4085794655414907,2.5388535526935234,['MAP3K8'],0.4408506249510454,0,0,1
117,Exercise-induced Circadian Regulation WP410,0.3485102913464345,2.4085794655414907,2.5388535526935234,['ERC2'],0.4408506249510454,0,0,1
118,Nuclear Receptors Meta-Pathway WP2882,0.3613710215880607,1.6092117758784426,1.6379363473696822,"['PLTP', 'HSPA1A']",0.4409287262688851,0,0,2
119,IL-3 signaling pathway WP286,0.36346827435678364,2.281145902731512,2.308663968128595,['CD69'],0.4409287262688851,0,0,1
120,Synaptic Vesicle Pathway WP2267,0.36346827435678364,2.281145902731512,2.308663968128595,['SYN3'],0.4409287262688851,0,0,1
121,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.36346827435678364,2.281145902731512,2.308663968128595,['PIM1'],0.4409287262688851,0,0,1
122,DNA IR-damage and cellular response via ATR WP4016,0.36346827435678364,2.281145902731512,2.308663968128595,['BCL6'],0.4409287262688851,0,0,1
123,MET in type 1 papillary renal cell carcinoma WP4205,0.37808702182260995,2.1664556962025316,2.107161739301105,['JAK3'],0.45254120141379434,0,0,1
124,AGE/RAGE pathway WP2324,0.3852715633657979,2.1133065761037355,2.015686254522786,['HIF1A'],0.45254120141379434,0,0,1
125,NRF2 pathway WP2884,0.3852715633657979,2.1133065761037355,2.015686254522786,['HSPA1A'],0.45254120141379434,0,0,1
126,Pathogenic Escherichia coli infection WP2272,0.3852715633657979,2.1133065761037355,2.015686254522786,['LY96'],0.45254120141379434,0,0,1
127,EGF/EGFR signaling pathway WP437,0.4024593389025643,1.470664928292047,1.3385421685602281,"['PLSCR1', 'LIMK2']",0.4690077335242481,0,0,2
128,Spinal Cord Injury WP2431,0.41319918686461854,1.9243319268635724,1.7007736459698217,['ZFP36'],0.4719539252110714,0,0,1
129,Non-small cell lung cancer WP4255,0.41319918686461854,1.9243319268635724,1.7007736459698217,['JAK3'],0.4719539252110714,0,0,1
130,IL-18 signaling pathway WP4754,0.41455412349621135,1.4335664335664335,1.2623294139675736,"['CD83', 'SPP1']",0.4719539252110714,0,0,2
131,Pathways in clear cell renal cell carcinoma WP4018,0.42668935342426334,1.8419068138971182,1.5687502652799283,['HIF1A'],0.4820612542503128,0,0,1
132,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4398731775799932,1.7662102815809868,1.4505334451113012,['IGF1'],0.4931911384987802,0,0,1
133,Thermogenesis WP4321,0.46534912870151257,1.6319560544542633,1.2483930831201393,['ACSL1'],0.5178321131415328,0,0,1
134,Senescence and Autophagy in Cancer WP615,0.47765454346326247,1.5721518987341772,1.161611974784675,['IGF1'],0.5275587494967376,0,0,1
135,Breast cancer pathway WP4262,0.4837019449352579,1.5438517179023508,1.1212784726850036,['IGF1'],0.5302806507438383,0,0,1
136,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.4896801981895936,1.5165445258716412,1.0828169736570952,['HIF1A'],0.53288727450044,0,0,1
137,Androgen receptor signaling pathway WP138,0.5072078328997234,1.440084388185654,0.9775788684984104,['LIMK2'],0.5479325494099202,0,0,1
138,TNF-alpha signaling pathway WP231,0.5185612654582068,1.393221723152307,0.914924664220922,['MAP3K8'],0.5521371747324793,0,0,1
139,DNA damage response (only ATM dependent) WP710,0.5185612654582068,1.393221723152307,0.914924664220922,['BCL6'],0.5521371747324793,0,0,1
140,Ectoderm Differentiation WP2858,0.5458271143831612,1.2883053088985452,0.7800083060751193,['PIM1'],0.5770172352050562,0,0,1
141,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.561448654132334,1.2325497287522604,0.7114707848632337,['HIF1A'],0.5893219915715279,0,0,1
142,B Cell Receptor Signaling Pathway WP23,0.5765393676895391,1.1813767990289579,0.6505979712250097,['BCL6'],0.6009001860426182,0,0,1
143,TGF-beta Signaling Pathway WP366,0.6232323778953575,1.0375171572365411,0.49057528775232506,['LIMK2'],0.6450237197798105,0,0,1
144,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6276121086582961,1.0250150693188669,0.47748580862086737,['MAP3K8'],0.6450457783432487,0,0,1
145,Circadian rhythm related genes WP3594,0.6687358248719378,0.9146242930245085,0.3680138805869477,['PER3'],0.682571738489978,0,0,1
146,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6948204344771893,0.8503571876174959,0.3096166119567043,['SPP1'],0.7043385226207125,0,0,1
147,Insulin Signaling WP481,0.7121999088086483,0.809648913303081,0.27479211766205436,['MAP3K8'],0.7170448061474826,0,0,1
148,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9613418811788247,0.30430379746835445,0.011997231268289974,['HSPA1A'],0.9613418811788247,0,0,1
